GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INSM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very red day for Insmed stock price after a -5.27% fall in the Thursday trading session
(Updated on Apr 18, 2024)

Sell candidate since Apr 12, 2024 Loss -8.99% PDF

The Insmed stock price fell by -5.27% on the last day (Thursday, 18th Apr 2024) from $26.18 to $24.80. During the last trading day the stock fluctuated 6.22% from a day low at $24.77 to a day high of $26.31. The price has been going up and down for this period, and there has been a -9.09% loss for the last 2 weeks. Volume has increased on the last day by 1 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $54.93 million.

The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($25.06) are considered to be a "second chance" to get out. According to the fan-theory $21.70 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INSM Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Insmed stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $26.88 and $27.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -13.17%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Insmed stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.54 between high and low, or 6.22%. For the last week, the stock has had daily average volatility of 4.17%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INSM) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Insmed to open at $25.29, and during the day (based on 14 day Average True Range), to move between $23.84 and $25.76, which gives a possible trading interval of +/-$0.96 (+/-3.87%) up or down from last closing price. If Insmed takes out the full calculated possible swing range there will be an estimated 7.75% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $27.28, some $2.48 (10.00%) from the current price of $24.80, our system finds the risk reward not very attractive.

Is Insmed stock A Buy?

Insmed holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.118 Strong Sell Candidate Downgraded

Predicted Opening Price for Insmed of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$25.29 ( 1.99%) $24.80

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INSM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 26.83 8.20 %
R2 26.25 5.83 %
R1 25.88 4.36 %
Current price: 24.80
Support S1 24.71 -0.383 %
S2 24.34 -1.85 %
S3 23.75 -4.22 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 28.75 15.93 %
R2 27.80 12.10 %
R1 27.28 10.00 %
Current price 24.80
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Insmed Stock and on which exchange is it traded?
The symbol for Insmed is INSM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Insmed Stock?
Insmed holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Insmed Stock?
Insmed Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Insmed Stock.

What's the current price of Insmed Stock?
As of the end of day on the 2024-04-18, the price of an Insmed (INSM) share was $24.80.

What is the 52-week high and low for Insmed Stock?
The 52-week high for Insmed Stock is $32.00 and the 52-week low is $17.41.

What is the market capitalization of Insmed Stock?
As of the 2024-04-18, the market capitalization of Insmed is 3.888B.

When is the next earnings date for Insmed?
The upcoming earnings date for Insmed is May 02, 2024.
Click to get the best stock tips daily for free!

About Insmed

Insmed Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT